» Articles » PMID: 35889786

Inosine Pretreatment Attenuates LPS-Induced Lung Injury Through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo

Overview
Journal Nutrients
Date 2022 Jul 27
PMID 35889786
Authors
Affiliations
Soon will be listed here.
Abstract

Inosine is a type of purine nucleoside, which is considered to a physiological energy source, and exerts a widely range of anti-inflammatory efficacy. The TLR4/MyD88/NF-κB signaling pathway is essential for preventing host oxidative stresses and inflammation, and represents a promising target for host-directed strategies to improve some forms of disease-related inflammation. In the present study, the results showed that inosine pre-intervention significantly suppressed the pulmonary elevation of pro-inflammatory cytokines (including tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)), malondialdehyde (MDA), nitric oxide (NO), and reactive oxygen species (ROS) levels, and restored the pulmonary catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and myeloperoxidase (MPO) activities (p < 0.05) in lipopolysaccharide (LPS)-treated mice. Simultaneously, inosine pre-intervention shifted the composition of the intestinal microbiota by decreasing the ratio of Firmicutes/Bacteroidetes, elevating the relative abundance of Tenericutes and Deferribacteres. Moreover, inosine pretreatment affected the TLR4/MyD88/NF-κB signaling pathway in the pulmonary inflammatory response, and then regulated the expression of pulmonary iNOS, COX2, Nrf2, HO-1, TNF-α, IL-1β, and IL-6 levels. These findings suggest that oral administration of inosine pretreatment attenuates LPS-induced pulmonary inflammatory response by regulating the TLR4/MyD88/NF-κB signaling pathway, and ameliorates intestinal microbiota disorder.

Citing Articles

Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut-brain axis.

Morshedbak M, Rahimi K, Tabandeh M Heliyon. 2025; 11(3):e42430.

PMID: 39995913 PMC: 11848074. DOI: 10.1016/j.heliyon.2025.e42430.


Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury.

Huang P, Liu Y, Li Y, Xin Y, Nan C, Luo Y BMC Med. 2025; 23(1):79.

PMID: 39934788 PMC: 11818193. DOI: 10.1186/s12916-025-03920-7.


Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies.

Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M Biomedicines. 2025; 12(12.

PMID: 39767682 PMC: 11673251. DOI: 10.3390/biomedicines12122776.


Imbalance of intestinal flora activates inflammatory response contributing to acute lung injury.

He Y, Wang S, Lu H, Zhang Q, Chen X, Yang Y J Thorac Dis. 2024; 16(10):6835-6848.

PMID: 39552844 PMC: 11565338. DOI: 10.21037/jtd-24-633.


Inosine reverses multidrug resistance in Gram-negative bacteria carrying mobilized RND-type efflux pump gene cluster .

Li F, Xu T, Fang D, Wang Z, Liu Y mSystems. 2024; 9(10):e0079724.

PMID: 39254032 PMC: 11495011. DOI: 10.1128/msystems.00797-24.


References
1.
Guo S, Guo L, Fang Q, Yu M, Zhang L, You C . Astaxanthin protects against early acute kidney injury in severely burned rats by inactivating the TLR4/MyD88/NF-κB axis and upregulating heme oxygenase-1. Sci Rep. 2021; 11(1):6679. PMC: 7988001. DOI: 10.1038/s41598-021-86146-w. View

2.
Abdelmegeed M, Yoo S, Henderson L, Gonzalez F, Woodcroft K, Song B . PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr. 2011; 141(4):603-10. PMC: 3056578. DOI: 10.3945/jn.110.135210. View

3.
Schieber M, Chandel N . ROS function in redox signaling and oxidative stress. Curr Biol. 2014; 24(10):R453-62. PMC: 4055301. DOI: 10.1016/j.cub.2014.03.034. View

4.
Zeng H, Ishaq S, Liu Z, Bukowski M . Colonic aberrant crypt formation accompanies an increase of opportunistic pathogenic bacteria in C57BL/6 mice fed a high-fat diet. J Nutr Biochem. 2017; 54:18-27. DOI: 10.1016/j.jnutbio.2017.11.001. View

5.
Gao J, Teng L, Yang S, Huang S, Li L, Zhou L . MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice. Biochem Pharmacol. 2021; 186:114499. PMC: 7957947. DOI: 10.1016/j.bcp.2021.114499. View